Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nurix Therapeutics (NRIX) Return on Assets (2020 - 2025)

Historic Return on Assets for Nurix Therapeutics (NRIX) over the last 6 years, with Q4 2025 value amounting to 0.44%.

  • Nurix Therapeutics' Return on Assets fell 1100.0% to 0.44% in Q4 2025 from the same period last year, while for Nov 2025 it was 0.44%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.39% for FY2025, which is 100.0% down from last year.
  • Per Nurix Therapeutics' latest filing, its Return on Assets stood at 0.44% for Q4 2025, which was down 1100.0% from 0.44% recorded in Q3 2025.
  • In the past 5 years, Nurix Therapeutics' Return on Assets registered a high of 0.14% during Q1 2021, and its lowest value of 0.45% during Q1 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.39% (2022), whereas its average is 0.35%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -2000bps in 2022, then surged by 1100bps in 2024.
  • Nurix Therapeutics' Return on Assets (Quarter) stood at 0.24% in 2021, then plummeted by -70bps to 0.41% in 2022, then dropped by -5bps to 0.43% in 2023, then rose by 25bps to 0.33% in 2024, then plummeted by -33bps to 0.44% in 2025.
  • Its last three reported values are 0.44% in Q4 2025, 0.44% for Q3 2025, and 0.34% during Q2 2025.